See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.
Phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer who are treated without surgery
eagle-i ID
http://hawaii.eagle-i.net/i/00000130-ddc2-2f61-9953-50a980000000
Resource Type
Properties
-
-
ClinicalTrials.gov url
-
http://www.clinicaltrials.gov/ct2/show/NCT00655876?term=RTOG-0436&rank=1
-
-
Intervention
-
Radiation therapy
-
-
Intervention
-
Paclitaxel
-
-
Intervention
-
Cisplatin
-
-
Intervention
-
Antineoplastic combined chemotherapy
-
-
Resource Description
-
This randomized phase III trial is comparing how well giving paclitaxel and cisplatin together with radiation therapy works with or without cetuximab in treating patients with locally advanced esophageal cancer.
-
-
Contact
-
Berenberg, Jeffrey
-
-
PI
-
Berenberg, Jeffrey
-
-
Topic
-
esophageal cancer
-
-
Study Population
-
Males and females ages 18 to 74 with histologically proven squamous cell or adenocarcinoma of the esophagus or gastroesophageal junction.
-
-
Website(s)
-
http://www.cancer.gov/clinicaltrials/featured/trials/rtog-0436
-
-
Website(s)
-
http://www.cancer.gov/clinicaltrials/search/view?cdrid=538085&version=healthprofessional
-
-
Funded by
-
Radiation Therapy Oncology Group
-
-
Phase
-
Phase 3 clinical trial
-
-
Performed by
-
Clinical Protocol & Data Management Shared Resource
